Technology

Within Histogen's proprietary bioreactors, newborn fibroblasts are seeded onto a beadlike structure and conditioned with liquid media. Within a few days cells have produced a dense embryonic-like ExceltrixTM and have secreted wnt proteins and various growth factors into the liquid that bathes them.
View the bioreactors in
action
Home > Technology > Patents

Our Patents
Two patents have been filed in the United States and Europe covering Histogen extracellular matrix. These patents are:

  • 2010/ 0047305 - Extracellular Matrix Compositions including Embryonic Proteins
  • 2010/ 0124573 - Extracellular Matrix Compositions for the Treatment of Cancer





Two patents have been filed in the United States and Europe covering Histogen extracellular matrix.
© Histogen Inc., CA 92121